FDA OKs two COVID-19 tests from Ender

By LabPulse.com staff writers

November 25, 2020 -- The U.S. Food and Drug Administration (FDA) has approved two COVID-19 tests made by Ender Diagnostics North America, the U.S. subsidiary of the Swiss-based Ender Diagnostics.

Ender Lab and Ender Mass are IVD test kits based on a rapid molecular isothermal nucleic acid amplification technology that are designed for use by laboratory professionals. Ender Lab provides results within 30 minutes after the extraction of the viral RNA, which makes it significantly faster than polymerase chain reaction (PCR) tests. It has a sensitivity of 97.7% and a specificity of 100%, according to the company.

The Ender Mass test does not require a conventional RNA extraction, and it detects the SARS-CoV-2 virus within 30 minutes after sample preparation.

Antigen tests drive COVID-19 test market to $10.5B
Rising use of antigen tests will drive the market for COVID-19 tests to $10.5 billion in revenues, according to a new market research report by Kalorama...
CMS to cut COVID-19 payments to slower labs
In a bid to speed up COVID-19 testing, the U.S. Centers for Medicare and Medicaid Services (CMS) has announced a new policy to pay for expedited COVID-19...
United Airlines launches pilot COVID-19 testing program
United Airlines has announced a pilot COVID-19 testing program for travelers in which customers traveling on United from San Francisco International Airport...
Rapid point-of-care COVID-19 test shows promise in clinical study
A rapid COVID-19 test that can produce results at the point of care in just 90 minutes without sending samples to a central lab has demonstrated 94% sensitivity...

Copyright © 2020 LabPulse.com

Last Updated ls 11/25/2020 3:54:35 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current